The recently appointed managing director of Pfizer Luxembourg discusses the current footprint of the company in the country; how every affiliate within the group counts; market access procedures; and the role of Luxembourg within the life sciences and healthcare sector.
Since September 2016, you have been managing director of Pfizer Luxembourg. What made you join the company?
"Luxembourg is a rather easy market to introduce a new product. Any product introduced in the country is actually first introduced in Belgium, where pricing is agreed upon and then followed in Luxembourg."
